Nykredit A S Invests $7.37 Million in Mettler-Toledo International, Inc. $MTD

Nykredit A S purchased a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 5,765 shares of the medical instruments supplier’s stock, valued at approximately $7,365,000.

A number of other hedge funds have also recently modified their holdings of the company. Geneos Wealth Management Inc. raised its stake in Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 30 shares during the period. Baird Financial Group Inc. grew its stake in shares of Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after buying an additional 40 shares during the period. Jump Financial LLC increased its holdings in shares of Mettler-Toledo International by 44.6% during the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after buying an additional 125 shares during the last quarter. Cerity Partners LLC increased its holdings in shares of Mettler-Toledo International by 10.8% during the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after buying an additional 392 shares during the last quarter. Finally, AXA S.A. raised its position in shares of Mettler-Toledo International by 2.9% during the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after buying an additional 131 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 0.8%

Shares of MTD stock opened at $1,344.87 on Friday. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The company has a 50 day moving average price of $1,361.63 and a 200 day moving average price of $1,274.73. The stock has a market capitalization of $26.95 billion, a P/E ratio of 30.27, a price-to-earnings-growth ratio of 2.77 and a beta of 1.22. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the business earned $10.09 EPS. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. Equities research analysts predict that Mettler-Toledo International, Inc. will post 47.35 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the sale, the chief executive officer directly owned 4,480 shares in the company, valued at approximately $6,384,000. This trade represents a 17.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 2,240 shares of Mettler-Toledo International stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total value of $3,207,680.00. Following the completion of the transaction, the chief financial officer owned 5,579 shares of the company’s stock, valued at approximately $7,989,128. This trade represents a 28.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 4,254 shares of company stock worth $6,092,712 over the last ninety days. Insiders own 0.71% of the company’s stock.

Wall Street Analyst Weigh In

MTD has been the subject of several analyst reports. Weiss Ratings upgraded Mettler-Toledo International from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 4th. Barclays lifted their target price on Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Royal Bank Of Canada began coverage on Mettler-Toledo International in a report on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 price target for the company. Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Robert W. Baird reduced their price objective on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $1,445.31.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.